Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PTPI Petros Pharmaceuticals Inc

0,2565

0,0092 (3,72%)

22 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Petros Pharmaceuticals (NASDAQ:PTPI)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Petros Pharmaceuticals Charts.

Petros Pharmaceuticals (NASDAQ:PTPI)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Petros Pharmaceuticals Charts.

News Petros Pharmaceuticals Inc

Form 8-K - Current report
Donnerstag 21 November 2024 (10 Stunden vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 18 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Freitag 25 Oktober 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 25 Oktober 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 18 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 17 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Dienstag 15 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 4 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 19 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Freitag 31 Mai 2024 (6 Monate vor) • Edgar (US Regulatory)

Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
Dienstag 14 Mai 2024 (6 Monate vor) • GlobeNewswire Inc.

Weitere Petros Pharmaceuticals Inc News-Artikel

BNP Paribas (QX)

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen